Amphotericin B and liver function
Authors:
- U InselmannUIU Inselmann
- H.T HeidemannHHH.T Heidemann
- 1 August 2002
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 13 (5) , 288-292
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Heat Treatment of Amphotericin B Modifies Its Serum Pharmacokinetics, Tissue Distribution, and Renal Toxicity following Administration of a Single Intravenous Dose to RabbitsAntimicrobial Agents and Chemotherapy, 2001
- Safety, Toxicokinetics and Tissue Distribution of Long-Term Intravenous Liposomal Amphotericin B (ambisome®): A 91-day Study in RatsPharmaceutical Research, 2000
- Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 1999
- A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patientsBritish Journal of Haematology, 1997
- AMPHOTERICIN B THERAPYInfectious Diseases in Clinical Practice, 1993
- Distribution and Activity of Amphotericin B in HumansThe Journal of Infectious Diseases, 1985
- Amphotericin B nephrotoxicity in humans decreased by salt repletionThe American Journal of Medicine, 1983
- Strategies in the Treatment of Systemic Fungal InfectionsNew England Journal of Medicine, 1980
- Fungal Sterols and the Mode of Action of the Polyene Antibiotics1974
- FATAL TOXIC REACTION TO AMPHOTERICIN B IN CRYPTOCOCCAL MENINGO-ENCEPHALITISAnnals of Internal Medicine, 1960